Combinations of immunosupressive agents for the treatment or prevention of graft rejections -> Monitor Keywords
Fresh Patents
Monitor Patents Patent Organizer File a Provisional Patent Browse Inventors Browse Industry Browse Agents Browse Locations
site info Site News  |  monitor Monitor Keywords  |  monitor archive Monitor Archive  |  organizer Organizer  |  account info Account Info  |  
12/15/05 - USPTO Class 514 |  60 views | #20050277585 | Prev - Next | About this Page  514 rss/xml feed  monitor keywords

Combinations of immunosupressive agents for the treatment or prevention of graft rejections

Title: Combinations of immunosupressive agents for the treatment or prevention of graft rejections


Related Patent Categories: Drug, Bio-affecting And Body Treating Compositions, Designated Organic Active Ingredient Containing (doai), Peptide Containing (e.g., Protein, Peptones, Fibrinogen, Etc.) Doai, Cyclopeptides, Monocyclic

Brief Patent Description - Full Patent Description - Patent Claims

The Patent Description & Claims data below is from USPTO Patent Application 20050277585, Combinations of immunosupressive agents for the treatment or prevention of graft rejections.


1-6. (canceled)

7. A Method of reducing early graft damage, improving early xenograft function or promoting long term survival of xenografts of a transgenic organ in human recipients comprising the steps of: (i) exposing body fluid removed from a human recipient with a xenoantigenic material or anti-human mono- or polyclonal antibodies or another antibody adsorbent, which is bound to a biocompatible solid support; (ii) reintroducing the treated body fluid into the human recipient, and (iii) treating the human recipient with a pharmaceutical composition comprising at least two immunosuppressant compounds selected from the group consisting of (a) IL-2 transcription inhibitors and (b) immunosuppressant compounds that immunosuppress for B-cell-mediated or antibody-mediated rejection of xenografts.

8. A method for reducing early graft damage, improving early xenograft function or promoting long term survival of xenografts of an organ transgenic for hDAF in human recipients comprising the steps of: (i) exposing body fluid removed from a human recipient with a xenoantigenic material or anti-human mono- or polyclonal antibodies or another antibody adsorbent, which is bound to a biocompatible solid support; (ii) reintroducing the treated body fluid into the human recipient, and (iii) treating the human recipient with a pharmaceutical composition comprising at least two immunosuppressant compounds selected from the group consisting of (a) IL-2 transcription inhibitors and (b) immunosuppressant compounds that immunosuppress for B-cell-mediated or antibody-mediated rejection of xenografts.

9. The method according to claim 7 wherein the steps (i) and (ii) are conducted postoperatively and in parallel with treatment with the pharmaceutical composition.

Brief Patent Description - Full Patent Description - Patent Claims

Click on the above for other options relating to this Combinations of immunosupressive agents for the treatment or prevention of graft rejections patent application.
###
monitor keywords

How KEYWORD MONITOR works... a FREE service from FreshPatents
1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored.
3. Each week you receive an email with patent applications related to your keywords.  
Start now! - Receive info on patent apps like Combinations of immunosupressive agents for the treatment or prevention of graft rejections or other areas of interest.
###


Previous Patent Application:
Histone deacetylase inhibitors and process for producing the same
Next Patent Application:
Pharmaceutical compositions comprising cyclosporins
Industry Class:
Drug, bio-affecting and body treating compositions

###

Design/code © 2009 FreshContext LLC/Freshpatents.com. Website Terms and Conditions - Also read: About this Page
Patent data source: patents published by the United States Patent and Trademark Office (USPTO)
Information published here is for research/educational purposes only (and in conjunction with our Keyword Monitor) and is not meant to be used in place of the full USPTO patent document/images or a comprehensive patent archive search. Complete official applications are on file at the USPTO and often contain additional data/images (Freshpatents is currently text-only). FreshPatents.com is not affiliated with or endorsed by the USPTO or firms/individuals or products/designs/ideas related to listed patents.
FreshPatents.com Support
Thank you for viewing the Combinations of immunosupressive agents for the treatment or prevention of graft rejections patent info.
IP-related news and info


Results in 0.31663 seconds


Other interesting Feshpatents.com categories:
Computers:  Graphics ,  I/O ,  Processors ,  Dyn. Storage ,  Static Storage ,  Printers 174
filepatents (1K)

* Protect your Inventions
* US Patent Office filing
patentexpress PATENT INFO